· Venture Capital Tracker · investment-strategies  · 1 min read

Week of May 18–23, 2026: $2.5B+ in Startup Funding — Modal, Decart, Hark Lead

AlleyWatch tracked 34 deals and $2.53B for the week ending May 23 — from Modal's $355M to Hark's $700M Series A, here's what mattered.

One week. $2.53 billion. If you’re not paying attention to May 18–23, 2026, you’re fundraising blind.

Top of the leaderboard

  1. Hark — $700M+ Series A @ $6B (personalized AI lab)
  2. Modal Labs — $355M Series C @ ~$4.65B (AI infra, NYC)
  3. Decart — $300M (world models; NVIDIA in round)
  4. Amca — $300M Series B (industrial base)
  5. Mercury — $200M @ $5.2B (startup banking)

Next tier still matters

  • Exa — $250M AI search @ $2.2B
  • RADAR — $170M retail AI (NYC)
  • Armada — $230M Series B @ $2B pre (edge/infra)
  • Farther — $150M wealth (NYC)
  • Primer — $100M payments AI

Three takeaways (no fluff)

1. AI dollars split three ways: models/worlds (Decart, Hark), infrastructure (Modal, Exa), applied verticals (RADAR, Moment).

2. Fintech is B2B again: Mercury through Checker — plumbing, not perks.

3. NYC punched up: Modal, RADAR, Farther, Nourish, Moment, Eisen — six figure-eight-figure deals in one ecosystem week.

What founders should do Monday morning

  • Update your comp set and valuation anchors.
  • Rewrite one slide: production metrics (stores, ARR, accuracy, AUM on platform).
  • Kill any sentence that says “we’re AI-powered” without saying what got better for the customer.

Sources

  1. AlleyWatch (5/25/26 report): https://alleywatch.com/2026/05/the-weekly-notable-startup-funding-report-5-25-26/
  2. Crunchbase biggest rounds (May 18–22): https://news.crunchbase.com/venture/biggest-funding-rounds-medical-devices-futuristic-ai-gadgets-frontier-labs-mirus/
  3. VC News Daily: https://vcnewsdaily.com/

By Venture Capital Tracker

Editorial note: AI tools assisted with research, structure, or drafting. Venture Capital Tracker retains human editorial responsibility for factual accuracy, relevance, and source quality before publication.

Frequently Asked Questions

Common questions about this topic

Back to Blog

Recommended next

Browse all research »

How Much Did AusperBio Raise? $120M Series C, No Valuation

AusperBio closed a $120 million Series C on August 27, 2026. An unnamed strategic investor led. RA Capital joined. The company cites $360 million raised since 2024. Valuation was not disclosed. AHB-137 is in Phase 3 in China and remains investigational.